• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 3
  3. Author

Online ISSN: 2515-8260

Volume9, Issue3

"AIDP: Another aspect of COVID 19"

    Dr. Pranita, Dr. Ajit Kumar, Dr. Abhinaya .

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 3, Pages 736-738

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

COVID-19 has presented predominantly with respiratorydisease, but neurological manifestations are being increasingly recognized including stroke, encephalitis, acute disseminated encephalomyelitis, and myelitis along with symptoms of peripheral nervous system, and as muscle diseases. The proposed mechanisms of neurological involvement are direct infection by the virus or inflammation of the nervous system and vasculature, which may be para-infectious or post infectious. [1]
This case of a 55-year-old woman from Central India presented with acute flaccid paralysis as Guillain-Barré syndrome due to COVID 19 infection. Guillain-Barré syndrome (GBS) is an acute, frequently severe, and fulminant polyradiculoneuropathy that is autoimmune in nature. It manifests as a rapidly evolving, ascending, areflexic motor paralysis with or without sensory disturbance. [2]
 
Keywords:
    COVID-19 has presented predominantly with respiratorydisease but neurological manifestations are being increasingly recognized including stroke encephalitis acute disseminated encephalomyelitis and myelitis along with symptoms of peripheral nervous system and as muscle diseases
  • PDF (132 K)
  • XML
(2022). "AIDP: Another aspect of COVID 19". European Journal of Molecular & Clinical Medicine, 9(3), 736-738.
Dr. Pranita, Dr. Ajit Kumar, Dr. Abhinaya .. ""AIDP: Another aspect of COVID 19"". European Journal of Molecular & Clinical Medicine, 9, 3, 2022, 736-738.
(2022). '"AIDP: Another aspect of COVID 19"', European Journal of Molecular & Clinical Medicine, 9(3), pp. 736-738.
"AIDP: Another aspect of COVID 19". European Journal of Molecular & Clinical Medicine, 2022; 9(3): 736-738.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 96
  • PDF Download: 105
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus